Standards were defined to meet the requirements of the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129 (Stem Cell Act 2005) and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264 (Stem Cell Act 2010). The overall goals of the Stem Cell Acts of 2005 and 2010 are to:
- Help more patients in need receive a bone marrow or umbilical cord blood transplant from an unrelated donor or cord blood unit
- Improve health outcomes of patients receiving a transplant
The standards and measurements are monitored and reported separately for each component of the C.W. Bill Young Cell Transplantation Program:
By measuring the results against these standards, HRSA can determine when the requirements of Stem Cell Acts 2005 and 2010 are being met and when improvements are needed.
